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Following the completion of the human genome sequence
and the concomitant technological innovations required for
whole genome analyses, the last decade has witnessed an
explosion of data and information concerning the posttran-
scriptional regulation of gene expression, in both patholog-
ical and nonpathological contexts. Among the most notable
posttranscriptional events studied are the widespread usage
of alternative splicing, the pleiotropic regulatory roles of
miRNAs, and breakthroughs in the understanding of the
control of gene expression by noncoding RNA transcripts.
In this special issue of this journal, the spotlight is cen-
tered on the role that various mechanisms of posttranscrip-
tional regulation—and the RNA binding proteins (RBPs) that
control them—play in cancer biology.
Adaptive changes in gene expression programs are crucial
during tumor development, in order to allow cancer cells
to support growth, survival, and metastasis and to resist to
therapeutic treatments. Cancer cells have now been shown
to efficiently adapt the expression of their proteome through
changes in alternative splicing patterns, modifications of
mRNA translational efficiency, or feedback modulators such
as miRNAs and noncoding RNAs.
RBPs play a pivotal role in these processes and many of
them are found aberrantly expressed in several tumor types.
Moreover, each RBPmost likely regulates a discrete but often
broad subset of target transcripts at the same time, thus
leading to an expanding functional network of changes that
have important consequences for cancer cell biology.
Several of these changes occur at the level of alternative
splicing, with the generation of variants that promote multi-
ple aspects of tumorigenesis. V. Pagliarini et al. in “Splicing
Regulation: A Molecular Device to Enhance Cancer Cell
Adaptation” review some of the most striking and best-char-
acterized examples of altered splicing events, which allow
cancer cells to rapidly adapt to the adverse conditions
encountered during the transformation process, leading to
chemoresistance. In this regard, the authors discuss the
possibility of new therapeutic protocols combining canonical
chemotherapy with novel tools targeting this adaptive splic-
ing response.
M.R. da Silva et al. in “SplicingRegulators andTheirRoles
in Cancer Biology and Therapy” explore the significance of
cancer-associated alternative splicing events and then focus
on the role of the major family of splicing regulators, SR
proteins, and the kinases that regulate their activities. Their
impact on cancer progression, as well as their possible use as
targets for novel anticancer therapies, are discussed.
V. Gonc¸alves and P. Jordan in “Posttranscriptional Reg-
ulation of Splicing Factor SRSF1 and Its Role in Cancer
Cell Biology” zoom in on the specific role played by one of
the best-characterized SR-family proteins, SRSF1 (formerly
SF2/ASF). Their review encompasses the posttranscriptional
modifications and deregulated expression that contribute to
transforming this essential splicing regulator into a powerful
oncoprotein.
Our current understanding of how SAM68, a multifunc-
tional member of the separate STAR (signal transduction
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and activation of RNA metabolism) family of RBPs, affects
key cellular regulatory circuitries and promotes cancer devel-
opment and progression is summarized by P. Frisone et al.
in “SAM68: Signal Transduction and RNA Metabolism in
Human Cancer.” In particular, the authors address how the
transcriptional and posttranscriptional regulation of gene
expressionmastered by SAM68 contributes to changes occur-
ring in cancer cells, thus opening the possibility of new
therapeutic approaches targeting SAM68 activities in cancer.
Finally, the original research paper by E. Hong et al.,
“Unravelling the RNA-Binding Properties of SAFB Proteins
in Breast Cancer Cells,” sheds light on the RNA-map of SAFB
protein in breast cancer cells and highlights the contribution
of this relative newcomer to the complex deregulated land-
scape of RNA processing in tumors.
Another set of manuscripts addresses regulatory events
involved in mRNA translation.
M. J. Halaby et al. in “Translational Control Protein
80 Stimulates IRES-Mediated Translation of p53 mRNA in
Response to DNA Damage” contribute an original research
paper on the regulation of cap-independent p53 protein
translation upon genotoxic stress. In particular, they identify
two novel regulators of the p53 Internal Ribosome Entry Site
(IRES): the translational control protein 80 (TCP80) and the
RNA helicase A (RHA). The functional interaction between
these two proteins becomes relevant for p53 induction and its
tumor suppressive function in response to DNA damage.
In addition, F. Han et al. in “Emerging Roles of MicroR-
NAs in EGFR-Targeted Therapies for Lung Cancer” review
our current knowledge concerning the role of the dereg-
ulation of the EGFR signaling pathway in lung cancer. In
particular, they discuss the involvement of miRNAs in the
development of drug resistance to anti-EGFR agents in lung
cancer cells, indicating their possible application as predictive
biomarkers for anti-EGFR therapy.
Finally, the original research paper by P. Cremaschi et
al., “An Association Rule Mining Approach to Discover
lncRNAs Expression Patterns in Cancer Datasets,” employs
a bioinformatic approach (ARM (Association Rule Mining)
methodology) for the meta-analysis of gene expression data.
The ARM algorithm was applied for the study of differential
expression profile of long noncoding RNAs (lncRNAs) in
multiple tumor types and resulted in the identification of
lncRNAs patterns differentially expressed in tumor versus
normal tissues.
We hope that this special issue will contribute to a more
thorough understanding of the role of posttranscriptional
regulation and RBPs in tumorigenesis. In particular, a better
comprehension of the molecular events that underlie malig-
nant transformation will reveal potential novel drug targets
for the development ofmore selective and effective anticancer
therapies or identify novel biomarkers for disease progression
or personalized patient stratification.
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